The treatment of cocaine use disorder
Open accessThe DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Abstract
Current treatments for cocaine use disorder are often ineffective; new treatments are needed and are under development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Psychosocial/behavioral interventions-such as contingency management, community reinforcement, and cognitive behavioral therapy -remain the standard and most reliably available practices for treatment of MUD (36) and CUD (37).”
From Clinical management of psychostimulant withdrawal: review of the evidence (2023) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Contingency management for treatment of substance use disorders: a meta‐analysis
Prendergast, M., Podus, D., Finney, J., Greenwell, L., & Roll, J. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01581.x · Cited by 877
Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence
Higgins, S. T. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070060011 · Cited by 806
Kampman, K., & Jarvis, M. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000166 · Cited by 678
Self-citationScofield, M. D., Heinsbroek, J. A., Gipson, C. D., Kupchik, Y. M., Spencer, S., Smith, A. C. W., Roberts-Wolfe, D., & Kalivas, P. W. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012484 · Cited by 598
Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction
Cornish, J. L., & Kalivas, P. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0006.2000 · Cited by 545
Volkow, N. D., Fowler, J. S., Logan, J., Alexoff, D., Zhu, W., Telang, F., Wang, G.-J., Jayne, M., Hooker, J. M., Wong, C., et al. (2009) · JAMA · doi:10.1001/jama.2009.351 · Cited by 529
Give them prizes and they will come: Contingency management for treatment of alcohol dependence.
Petry, N. M., Martin, B., Cooney, J. L., & Kranzler, H. R. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.68.2.250 · Cited by 515
Behavioral Therapies for Drug Abuse
Carroll, K. M., & Onken, L. S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1452 · Cited by 459
Carroll, K. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950120061010 · Cited by 409
Carroll, K. M., Ball, S. A., Martino, S., Nich, C., Babuscio, T. A., Nuro, K. F., Gordon, M. A., Portnoy, G. A., & Rounsaville, B. J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111835 · Cited by 405
Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011-2016.
Hedegaard, H. B., Bastian, B. A., Trinidad, J. P., Spencer, M. R. T., & Warner, M. (2018) · PubMed · Cited by 394
A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300600 · Cited by 391
Self-citationSilverman, K. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050045007 · Cited by 379
Higgins, S. T., Wong, C. J., Badger, G. J., Ogden, D. E. H., & Dantona, R. L. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.68.1.64 · Cited by 352
Gibbs, J. W., Sombati, S., DeLorenzo, R. J., & Coulter, D. A. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02164.x · Cited by 348
A pilot trial of topiramate for the treatment of cocaine dependence
Kampman, K. M., Pettinati, H., Lynch, K. G., Dackis, C., Sparkman, T., Weigley, C., & O’Brien, C. P. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.03.008 · Cited by 313
Self-citationRawson, R. A., Huber, A., McCann, M., Shoptaw, S., Farabee, D., Reiber, C., & Ling, W. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.9.817 · Cited by 290
De Crescenzo, F., Ciabattini, M., D’Alò, G. L., De Giorgi, R., Del Giovane, C., Cassar, C., Janiri, L., Clark, N., Ostacher, M. J., & Cipriani, A. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002715 · Cited by 274
Schmidt, H. D., & Pierce, R. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05144.x · Cited by 254
Dextroamphetamine for Cocaine-Dependence Treatment: A Double-Blind Randomized Clinical Trial
Grabowski, J., Rhoades, H., Schmitz, J., Stotts, A., Daruzska, L. A., Creson, D., & Moeller, F. G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00010 · Cited by 243
Rawson, R. A., McCann, M. J., Flammino, F., Shoptaw, S., Miotto, K., Reiber, C., & Ling, W. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01312.x · Cited by 238
Modafinil for the treatment of cocaine dependence
Anderson, A. L., Reid, M. S., Li, S.-H., Holmes, T., Shemanski, L., Slee, A., Smith, E. V., Kahn, R., Chiang, N., Vocci, F., et al. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.015 · Cited by 235
Dewey, S., Smith, G., Logan, J., Brodie, J., Yu, D., Ferrieri, R., King, P., MacGregor, R., Martin, T., & Wolf, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-10-03773.1992 · Cited by 211
Baclofen Attenuates the Reinforcing Effects of Cocaine in Rats
Roberts, D. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(96)00002-4 · Cited by 193
A double-blind, placebo-controlled trial of modafinil for cocaine dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Plebani, J. G., Pettinati, H. M., Sparkman, T., & O'Brien, C. P. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.12.014 · Cited by 187
Self-citationModafinil and cocaine: a double-blind, placebo-controlled drug interaction study
Dackis, C. A., Lynch, K. G., Yu, E., Samaha, F. F., Kampman, K. M., Cornish, J. W., Rowan, A., Poole, S., White, L., & O'Brien, C. P. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00335-6 · Cited by 186
Self-citationGrabowski, J., Rhoades, H., Stotts, A., Cowan, K., Kopecky, C., Dougherty, A., Moeller, F. G., Hassan, S., & Schmitz, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300392 · Cited by 185
Levin, F. R., Mariani, J. J., Specker, S., Mooney, M., Mahony, A., Brooks, D. J., Babb, D., Bai, Y., Eberly, L. E., Nunes, E. V., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.41 · Cited by 179
Carroll, K. M., Kiluk, B. D., Nich, C., Gordon, M. A., Portnoy, G. A., Marino, D. R., & Ball, S. A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070987 · Cited by 177
Smoked Cocaine Self-Administration is Decreased by Modafinil
Hart, C. L., Haney, M., Vosburg, S. K., Rubin, E., & Foltin, R. W. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301472 · Cited by 174
Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses
Butler, A. J., Rehm, J., & Fischer, B. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.08.036 · Cited by 174
The Role of Acetylcholine in Cocaine Addiction
Williams, M. J., & Adinoff, B. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301585 · Cited by 173
Shiels, M. S., Freedman, N. D., Thomas, D., & Berrington de Gonzalez, A. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1812 · Cited by 167
Maude-Griffin, P. M., Hohenstein, J. M., Humfleet, G. L., Reilly, P. M., Tusel, D. J., & Hall, S. M. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.5.832 · Cited by 162
Topiramate for the Treatment of Cocaine Addiction: A Randomized Clinical Trial
Johnson, B. A., Ait-Daoud, N., Wang, X.-Q., Penberthy, J. K., Javors, M. A., Seneviratne, C., & Liu, L. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2295 · Cited by 133
Kampman, K. M., Alterman, A. I., Volpicelli, J. R., Maany, I., Muller, E. S., Luce, D. D., Mulholland, E. M., Jawad, A. F., Parikh, G. A., Mulvaney, F. D., et al. (2001) · Psychology of Addictive Behaviors · doi:10.1037//0893-164x.15.1.52 · Cited by 132
Self-citationTreatment Outcome Predictors for Cocaine Dependence
Poling, J., Kosten, T. R., & Sofuoglu, M. (2007) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990701199416 · Cited by 131
Varenicline for Tobacco Dependence
Hays, J. T., & Ebbert, J. O. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0800146 · Cited by 129
Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial
Mooney, M. E., Herin, D. V., Schmitz, J. M., Moukaddam, N., Green, C. E., & Grabowski, J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.10.016 · Cited by 124
Kushner, S. A., Dewey, S. L., & Kornetsky, C. H. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34966-3 · Cited by 123
Effectiveness and Costs of Inpatient versus Day Hospital Cocaine Rehabilitation
ALTERMAN, A. I., O??BRIEN, C. P., McLELLAN, A. T., AUGUST, D. S., SNIDER, E. C., DROBA, M., CORNISH, J. W., HALL, C. P., RAPHAELSON, A. H., & SCHRADE, F. X. (1994) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199403000-00005 · Cited by 120
GABAergic attenuation of cocaine-induced dopamine release and locomotor activity
Dewey, S. L., Chaurasia, C. S., Chen, C.-E., Volkow, N. D., Clarkson, F. A., Porter, S. P., Straughter-Moore, R. M., Alexoff, D. L., Tedeschi, D., Russo, N. B., et al. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199704)25:4<393::aid-syn11>3.0.co;2-w · Cited by 119
Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy
Petroff, O. A. C., Hyder, F., Mattson, R. H., & Rothman, D. L. (1999) · Neurology · doi:10.1212/wnl.52.3.473 · Cited by 119
Kampman, K. M., Pettinati, H. M., Lynch, K. G., Spratt, K., Wierzbicki, M. R., & O’Brien, C. P. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.05.026 · Cited by 115
Self-citationKushner, S. A., Dewey, S. L., & Kornetsky, C. H. (1999) · PubMed · Cited by 114
Topiramate increases cerebral GABA in healthy humans
Kuzniecky, R., Hetherington, H., Ho, S., Pan, J., Martin, R., Gilliam, F., Hugg, J., & Faught, E. (1998) · Neurology · doi:10.1212/wnl.51.2.627 · Cited by 112
Brief coping skills treatment for cocaine abuse: substance use outcomes at three months
MONTI, P. M., ROHSENOW, D. J., MICHALEC, E., MARTIN, R. A., & ABRAMS, D. B. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02892.x · Cited by 104
Gerasimov, M. R., Ashby, C. R., Gardner, E. L., Mills, M. J., Brodie, J. D., & Dewey, S. L. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199910)34:1<11::aid-syn2>3.0.co;2-5 · Cited by 96
Kampman, K. M., Lynch, K. G., Pettinati, H. M., Spratt, K., Wierzbicki, M. R., Dackis, C., & O’Brien, C. P. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.08.005 · Cited by 90
Self-citationNuijten, M., Blanken, P., van de Wetering, B., Nuijen, B., van den Brink, W., & Hendriks, V. M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00205-1 · Cited by 87
Glutamatergic Agents for Cocaine Dependence
DACKIS, C., & O'BRIEN, C. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.021 · Cited by 86
Predictors of Treatment Outcome in Outpatient Cocaine and Alcohol Dependence Treatment
Ahmadi, J., Kampman, K. M., Oslin, D. M., Pettinati, H. M., Dackis, C., & Sparkman, T. (2009) · The American Journal on Addictions · doi:10.1080/10550490802545174 · Cited by 86
Self-citationMariani, J. J., Pavlicova, M., Bisaga, A., Nunes, E. V., Brooks, D. J., & Levin, F. R. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.032 · Cited by 85
Modafinil and Cocaine Interactions
Malcolm, R., Swayngim, K., Donovan, J. L., DeVane, C. L., Elkashef, A., Chiang, N., Khan, R., Mojsiak, J., Myrick, D. L., Hedden, S., et al. (2006) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990600920425 · Cited by 85
Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network
Stitzer, M. L., Petry, N. M., & Peirce, J. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.12.010 · Cited by 70
Carroll, K. M., Nich, C., DeVito, E. E., Shi, J. M., & Sofuoglu, M. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11669 · Cited by 64
Umbricht, A., DeFulio, A., Winstanley, E. L., Tompkins, D. A., Peirce, J., Mintzer, M. Z., Strain, E. C., & Bigelow, G. E. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.03.033 · Cited by 57
Effects of modafinil-induced wakefulness on glutamine synthetase regulation in the rat brain
Touret, M., Sallanon, M. M., Fages, C., Roudier, V., Didier‐Bazès, M., Roussel, B., Tardy, M., & Jouvet, M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90082-5 · Cited by 46
Verrico, C. D., Haile, C. N., Mahoney III, J. J., Thompson-Lake, D. G. Y., Newton, T. F., & De La Garza II, R. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.05.008 · Cited by 44
McLellan, A. T., Hagan, T. A., Meyers, K., Randall, M., & Durell, J. (1997) · Journal of Addictive Diseases · doi:10.1300/j069v16n02_05 · Cited by 41
Nuijten, M., Blanken, P., van den Brink, W., & Hendriks, V. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.02.024 · Cited by 38
Smoking Cessation Pharmacotherapy—Nicotine and Non‐Nicotine Preparations
Frishman, W. H. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.05963.x · Cited by 36
The effectiveness of two intensities of psychosocial treatment for cocaine dependence.
Coviello, D. M., Alterman, A., Rutherford, M., Cacciola, J., McKay, J. R., & Zanis, D. A. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00136-8 · Cited by 32
Baldaçara, L., Cogo-Moreira, H., Parreira, B. L., Diniz, T. A., Milhomem, J. J., Fernandes, C. C., & Lacerda, A. L. T. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09377 · Cited by 30
Effects of Galantamine on Cocaine Use in Chronic Cocaine Users: Galantamine and Cocaine Use
Sofuoglu, M., & Carroll, K. M. (2011) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00130.x · Cited by 29
A Retrospective Investigation of an Intensive Outpatient Substance Abuse Treatment Program
Fishman, J., Reynolds, T., & Riedel, E. (1999) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-100101854 · Cited by 25
Nuijten, M., Blanken, P., van den Brink, W., & Hendriks, V. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115582151 · Cited by 23
Efficacy of Outpatient Intensive Treatment for Drug Abuse
Campbell, J. L., Gabrielli, W. F., Laster, L. J., & Liskow, B. I. (1997) · Journal of Addictive Diseases · doi:10.1300/j069v16n02_02 · Cited by 18
Patkar, A. A., Thornton, C. C., Berrettini, W. H., Gottheil, E., Weinstein, S. P., & Hill, K. P. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00237-4 · Cited by 17
Pirnia, B., Soleimani, A. A., Malekanmehr, P., Pirnia, K., & Zahiroddin, A. (2018) · PubMed Central · Cited by 6
Cited by
Microneedle patch for the ultrasensitive quantification of protein biomarkers in interstitial fluid
Wang, Z., Luan, J., Seth, A., Liu, L., You, M., Gupta, P., Rathi, P., Wang, Y., Cao, S., Jiang, Q., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00672-y · Cited by 386
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Klausen, M. K., Thomsen, M., Wortwein, G., & Fink‐Jensen, A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15677 · Cited by 259
“It is also suggested that individuals suffering from obesity and individuals suffering from addiction have overlapping brain dysregulations, and the anti-obesity effects of GLP-1 receptor agonists support the potential usefulness of GLP-1 receptor agonists for the treatment of SUD and AUD.”
BackgroundInfluentialThe Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms
Jones, C. M., Bekheet, F., Park, J. N., & Alexander, G. C. (2020) · Epidemiologic Reviews · doi:10.1093/epirev/mxaa011 · Cited by 188
Roque Bravo, R., Faria, A. C., Brito-da-Costa, A. M., Carmo, H., Mladěnka, P., Dias da Silva, D., Remião, F., & Researchers, O. B. O. T. O. (2022) · Toxins · doi:10.3390/toxins14040278 · Cited by 161
Tardelli, V. S., Bisaga, A., Arcadepani, F. B., Gerra, G., Levin, F. R., & Fidalgo, T. M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05563-3 · Cited by 151
Metadata
- Authors
- Kampman, K. M.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kampman, Kyle M.
- ORCID
- Kampman, Kyle M.
- Venue
- Science Advances
- Published
- 2019-10-11
- Volume
- 5
- Issue
- 10
- Pages
- eaax1532-eaax1532
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6795516
- OpenAlex
- W2981018657
- Cited by
- 250
- References
- 71
- Citations by year
- 2026: 34 · 2025: 45 · 2024: 43 · 2023: 41 · 2022: 47 · 2021: 28 · 2020: 12
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- cocaine dependence, cocaine addiction treatment, psychosocial interventions, contingency management, cognitive behavioral therapy, drug augmentation, dopamine agonists, modafinil, topiramate, glutamatergic agents, GABAergic agents, combination drugs
- MeSH terms
- Animals, Cocaine, Humans, United States, Dopamine Agonists, Cocaine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.